What role does DNA Stoffwechseltest play in blood sugar?

A DNA metabolism test that analyzes variants like FTO (rs9939609) or TCF7L2 is often marketed to provide personalized dietary advice for blood sugar control. However, the scientific evidence is sobering: an IPD meta-analysis of 8 randomized trials (n=9563) showed that the FTO genotype does not predict whether a person responds better to a low-fat or low-carb diet. For TCF7L2, results are conflicting. While these genes are biologically plausible in glucose metabolism, effect sizes are small and heavily overshadowed by environmental factors, gut microbiome, and lifestyle. Therefore, such a DNA test cannot reliably predict individual blood sugar responses. It may serve as inspiration but not as a medical decision tool. Clinical blood sugar measurements (fasting glucose, HbA1c, OGTT) remain the gold standard. Beware of overclaiming: most commercial tests exaggerate clinical relevance. Evidence: human-strong for lack of predictive power of FTO, overall mixed.